Nuwellis Reveals Aquadex System Success in Liver Disease

Nuwellis (NUWE) has released an update.

Nuwellis, Inc. has announced significant findings showing the effectiveness of their Aquadex SmartFlow® system for patients with severe liver disease experiencing fluid overload. The press release detailing these results emphasizes the system’s potential benefits, marking a noteworthy development in the treatment of end-stage liver disease related complications.

For further insights into NUWE stock, check out TipRanks’ Stock Analysis page.

For a comprehensive understanding of the announcement, you can read the full document here.